Expertise in
29
conditions

Dr. Marlyn J. Mayo

Gastroenterology
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 
Expertise in
29
conditions
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 

Overview

Marlyn Mayo is a Gastroenterologist practicing medicine in Dallas, Texas.

Dr. Mayo is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Primary Biliary Cholangitis, Cholestasis, Cholangitis, Cirrhosis, and Liver Transplant.

She is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 8 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in TX

Hospital Affiliations

Parkland Health & Hospital System
UT Of Texas Southwestern University Hospital - William P. Clements Jr.

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

University of Texas Southwestern Medical Center
5323 Harry Hines Blvd, Dallas, TX 75390
Other Locations
Dallas County Hospital District
5200 Harry Hines Blvd, Dallas, TX 75235

Additional Areas of Focus

Dr. Mayo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
Enrollment Status: Completed
Publish Date: August 25, 2026
Intervention Type: Drug
Study Drug: HTD1801 (BUDCA)
Study Phase: Phase 2
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: June 22, 2026
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Enrollment Status: Completed
Publish Date: February 18, 2026
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

84 Total Publications

Cholestatic Pruritus: A Review of Pathophysiology, Clinical Manifestations, and Therapeutic Landscape.
Cholestatic Pruritus: A Review of Pathophysiology, Clinical Manifestations, and Therapeutic Landscape.
Journal: Clinics in liver disease
Published: July 22, 2026
Similar Doctors
Expertise in
42
conditions
Dr. Paul R. Tarnasky
Gastroenterology
Expertise in
42
conditions
Dr. Paul R. Tarnasky
Gastroenterology
Referral may be required
Before you request

Physician Associates Of Southwest Dallas

122 W Colorado Blvd, 
Dallas, TX 
 (3.8 miles away)
214-947-6700
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Tarnasky is a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Tarnasky is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Acute Pancreatitis, Pancreas Divisum, Endoscopy, and Gastric Bypass. Dr. Tarnasky is board certified in Gastroenterology- American Board Of Internal Medicine, Gastroenterology- American Board Of Internal Med, and Gastroenterology- American Board Of Internal Med/Gastroenterology. Dr. Tarnasky is currently accepting new patients.

Expertise in
11
conditions
Dr. Stuart J. Spechler
Gastroenterology
Expertise in
11
conditions
Dr. Stuart J. Spechler
Gastroenterology
Referral may be required

Select Specialty Hospital-Dallas Downtown

3500 Gaston Ave, 
Dallas, TX 
 (3.8 miles away)
214-865-2241
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stuart Spechler is a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Spechler is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Barrett Esophagus, Esophagitis, Endoscopy, and Colonoscopy.

Expertise in
53
conditions
Dr. Prashant S. Kedia
Gastroenterology
Expertise in
53
conditions
Dr. Prashant S. Kedia
Gastroenterology
Referral may be required
Before you request

Physician Associates Of Southwest Dallas

122 W Colorado Blvd, 
Dallas, TX 
 (3.8 miles away)
214-947-6700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Prashant Kedia is a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Kedia is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Achalasia, Acute Pancreatitis, Endoscopy, and Gastric Bypass. Dr. Kedia is board certified in Gastroenterology- American Board Of Internal Medicine, Gastroenterology- American Board Of Internal Med, and Gastroenterology- American Board Of Internal Med/Gastroenterology. Dr. Kedia is currently accepting new patients.

Frequently Asked Questions about Dr. Marlyn J. Mayo

How do I make an appointment with Dr. Marlyn J. Mayo?

You can book an appointment with Dr. Marlyn J. Mayo by calling their office at 214-645-8600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marlyn J. Mayo a top-rated expert for Primary Biliary Cholangitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marlyn J. Mayo is classified as an Elite expert for Primary Biliary Cholangitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marlyn J. Mayo specialize in?

While Dr. Marlyn J. Mayo is a Gastroenterology, they have specific expertise in Primary Biliary Cholangitis, Cholestasis, and Cholangitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Marlyn J. Mayo participate in research or clinical trials?

Yes. Dr. Marlyn J. Mayo has published 84 articles and abstracts on conditions like Primary Biliary Cholangitis. You can view a list of Dr. Marlyn J. Mayo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marlyn J. Mayo accept my insurance?

Dr. Marlyn J. Mayo accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-645-8600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mayo's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 15 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile